The H1N1 vaccine is doing more, and less, than it’s supposed to. According to reports from both ABC News and MSNBC.com, the swine flu vaccine is not always providing the necessary safeguard against the swine flu, and is even ladling some users with unwanted side effects in the form of allergic reactions.
An ABCNews.com report has revealed that a batch of the H1N1 vaccine has been recalled in Canada. Its maker, U.K.-based GlaxoSmithKline, has recalled the vaccine because it has caused at least six known cases of severe allergic reaction in its users. So far, 170,000 doses of the vaccine have been recalled in Canada. Although reports claim that this side effect is limited to the vaccine distributed in Canada, it has yet to be seen whether or not other users in different locations are also affected by this defect. A total of 7.5 million doses of the vaccine have been distributed in Canada thus far.
MSNBC.com reports a completely different issue, this time one that has affected children. According to the article, over 800,000 doses of the H1N1 vaccine have been recalled by Sanofi Pasteur, the vaccine’s division of France-based pharmaceutical company Sanofi-Aventis Group. It has been determined that these particular doses of the vaccine are ineffective in preventing the onset of swine flu, thus putting children inoculated with the vaccine at risk of contracting the illness. The doses in question have minimal to no potency, and were distributed amongst children.